Life science tools company Partillion Bioscience Corporation announced on Monday that it has started taking pre-orders for its Nanovial Multicell Assay Antibody Discovery Kits.
The Multicell Assay platform, which enables the co-loading of cell pairs to study cell-to-cell interactions, has been named a finalist for the Society for Laboratory Automation and Screening (SLAS) 2025 New Product Award.
At SLAS 2025, Partillion will showcase its Nanovial Multicell Antibody Discovery Kits which leverage larger 50 micrometre diameter EZM Nanovials to enable loading of target cells and antibody-secreting cells together, unlocking the ability to screen hundreds of thousands of antibody secreting cells based on antibody binding on a target cell for therapeutic development.
This platform builds on the success of Partillion's original Nanovial format, which earned the SLAS New Product Award in 2022.
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
Insmed receives highest ranking in Science's 2024 Top Employers Survey
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions